The announcement comes just after Dexcom, another diabetes company, released its own consumer-friendly sensor. Here's what to ...

A news release from the National Institutes of Health (NIH) said that, "scientists are not clear how metformin may prevent ...

The stakes are extremely high for the nearly 40 million Americans living with diabetes. This condition happens when the body doesn't produce enough insulin or i ...

A pair of recent studies highlighted two potential new uses for metformin, a Type 2 diabetes drug. One points to the drug possibly helping people living with HIV, and another shows the drug could ...

(HealthDay News) — After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, prevalent metformin use is ...

The recall was initiated after the company found that there was a risk for inaccurate high glucose readings.

Let's not forget about Abbott Laboratories' impressive streak of 52 consecutive annual dividend increases, which also makes ...

New over-the-counter sensors, an Abbott-Medtronic partnership and Roche’s first CGM are among diabetes technology’s top stories so far in 2024. Check out MedTech Dive’s roundup of the latest news.

Priced at $49 for one 14-day sensor, or $89 per month, Abbott’s offering is competitive with Dexcom’s Stelo sensor.

Abbott has announced the U.S. availability of Lingo, the company’s first glucose monitoring system available without ...

Kiss a Pig Gala is the largest event in the state raising awareness and money for Diabetes research, advocacy and community ...

Reports Favorable National Health Strategies and Advancements in Glucose Monitoring Technologies Fuel Market Growth at a CAGR ...